'The Global Urology Devices Market Will Be Worth $8.6bn by 2022' Says Visiongain Report
LONDON, November 5, 2012 /PRNewswire/ --
A new report by Visiongain, a London-based business information provider, predicts that the global market for urology devices will be worth $8.6bn by 2022. The market-generated sales of $4.4bn in 2011. Similar to other markets in the medical device industry, the urology device market remained under pressure in 2011 owing primarily to increased pricing pressures. However, the market was still able to expand, with growth being fuelled by a number of factors, including patient demographics and continued advancements in minimally invasive and non-invasive surgical technologies in the urology field. The market is currently comprised of innovative urology devices for the treatment of a wide range of disorders that include urinary incontinence, prostate cancer, benign prostatic hyperplasia and kidney stones.
Rodrigo Gutierrez Gamboa, healthcare industry analyst, says: "Patient demographics and a strong R&D pipeline will continue to drive growth across all segments of the urology devices market over the forecast period. There will be a sustained influx of innovative and cost-effective urology technologies in the coming years that will continue to offset economic pressures in key regional markets. Pricing pressures have led R&D investments to be primarily focused on developing cost-effective technologies with improved safety profiles and ones that are able to streamline procedures. Over the next decade, innovation will thus be completely focused on the ability to achieve excellent clinical outcomes".
Visiongain's research also suggests that the world urology devices market may benefit from globalisation. There has been a steady rise in healthcare spending and medical insurance cover in countries such as Brazil, Russia, India and China (BRIC nations), owing to their rapidly growing economies. As a result, a greater proportion of the patient population will now be able to afford the treatments available, which will further strengthen demand in this sector.
Visiongain predicts that this market will grow steadily to 2022. The future of the urology devices market appears promising and has significant potential for growth and investment with the increasing demand for safer and cost-effective therapies. This new report adds to visiongain's wide range of analytical reports in healthcare and other industry areas.
For sample pages and further information concerning the Visiongain report Urology Devices: World Market Outlook 2012-2022 please visit http://www.visiongain.com/Report/925/Urology-Devices-World-Market-Outlook-2012-2022
For an executive summary please contact:
e-mail: Sara Peerun on email@example.com
Allengers Medical Systems
American Medical Systems
Asahi Kasei Corporation
Augmenix Inc (US)
B.Braun Melsungen AG
Dornier MedTech GmbH
EDAP TMS SA
Electro Medical Systems
Endo Health Solutions
First Quality Enterprises
Fresenius Medical Care
Hunter Urology (UK)
Johnson & Johnson
Medical Service (Germany)
Mpathy Medical Devices
Olympus Medical Systems Corp
Richard Wolf GmbH
Storz Medical AG
Svenska Cellulosa Aktiebolaget SCA
Varian Medical Systems
Notes for Editors
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44(0)207-336-6100